Institutional & Family Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $155K | Sell |
330
-44
| -12% | -$20.6K | 0.02% | 157 |
|
|
2024
Q1 | $156K | Sell |
374
-39
| -9% | -$16.3K | 0.02% | 153 |
|
|
2023
Q4 | $168K | Sell |
413
-22
| -5% | -$8.95K | 0.03% | 151 |
|
|
2023
Q3 | $151K | Sell |
435
-20
| -4% | -$6.96K | 0.02% | 150 |
|
|
2023
Q2 | $160K | Sell |
455
-14
| -3% | -$4.93K | 0.03% | 152 |
|
|
2023
Q1 | $148K | Sell |
469
-21
| -4% | -$6.62K | 0.02% | 149 |
|
|
2022
Q4 | $142K | Sell |
490
-14
| -3% | -$4.04K | 0.02% | 148 |
|
|
2022
Q3 | $146K | Sell |
504
-55
| -10% | -$15.9K | 0.03% | 150 |
|
|
2022
Q2 | $158K | Sell |
559
-55
| -9% | -$15.5K | 0.03% | 147 |
|
|
2022
Q1 | $160K | Sell |
614
-5
| -0.8% | -$1.3K | 0.03% | 159 |
|
|
2021
Q4 | $136K | Hold |
619
| – | – | 0.02% | 180 |
|
|
2021
Q3 | $112K | Hold |
619
| – | – | 0.02% | 226 |
|
|
2021
Q2 | $125K | Hold |
619
| – | – | 0.02% | 213 |
|
|
2021
Q1 | $133K | Buy |
619
+93
| +18% | +$20K | 0.03% | 230 |
|
|
2020
Q4 | $124K | Buy |
526
+18
| +4% | +$4.24K | 0.03% | 230 |
|
|
2020
Q3 | $138K | Buy |
508
+88
| +21% | +$23.9K | 0.03% | 198 |
|
|
2020
Q2 | $122K | Buy |
420
+19
| +5% | +$5.52K | 0.03% | 216 |
|
|
2020
Q1 | $95K | Sell |
401
-27
| -6% | -$6.4K | 0.02% | 207 |
|
|
2019
Q4 | $94K | Sell |
428
-5
| -1% | -$1.1K | 0.02% | 243 |
|
|
2019
Q3 | $73K | Sell |
433
-1
| -0.2% | -$169 | 0.02% | 258 |
|
|
2019
Q2 | $80K | Buy |
434
+12
| +3% | +$2.21K | 0.02% | 258 |
|
|
2019
Q1 | $78K | Sell |
422
-17
| -4% | -$3.14K | 0.02% | 272 |
|
|
2018
Q4 | $73K | Hold |
439
| – | – | 0.02% | 270 |
|
|
2018
Q3 | $85K | Hold |
439
| – | – | 0.02% | 290 |
|
|
2018
Q2 | $75K | Hold |
439
| – | – | 0.02% | 312 |
|
|
2018
Q1 | $72K | Buy |
+439
| New | +$72K | 0.02% | 287 |
|